Key result
Authors defend self-monitoring of blood glucose in type 2 diabetes, citing flawed and outdated evidence.
Answers are grounded in this paper and cite their sources.
We were disappointed with the conclusions of Harris (1) and the accompanying editorial (2) on self-monitoring of blood glucose (SMBG). The article is based on outdated data and reflects an era with much less SMBG capability and convenience, reimbursement, therapeutic modalities, and evidence for the benefits of improved glycemic control. Moreover, the study itself was uncontrolled, self-reported, and did not indicate whether the patients were taught about data usage. It would be unfortunate if this article and editorial were used to justify denial of appropriate reimbursement for SMBG in type 2 diabetes. Optimal modern therapy of type 2 diabetes uses a “treat-to-target” approach, expeditiously moving patients along a …
No takes yet. Share an insight, caveat, or question.
Blonde et al. (2002) conducted a letter in Type 2 diabetes. Self-monitoring of blood glucose (SMBG) was evaluated. Self-monitoring of blood glucose in type 2 diabetes was defended by the authors, who argued that recent critical conclusions were based on outdated, uncontrolled, and self-reported data.
Synapse has enriched 10 related papers. Consider them for comparative context: